These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8750111)

  • 1. Frequency of CYP2D6 allelic variants in multiple sclerosis.
    Agúndez JA; Arroyo R; Ledesma MC; Martínez C; Ladero JM; de Andrés C; Jiménez-Jiménez FJ; Molina JA; Alvarez-Cermeño JC; Varela de Seijas E
    Acta Neurol Scand; 1995 Dec; 92(6):464-7. PubMed ID: 8750111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP2D6 polymorphism is not associated with essential tremor.
    Agúndez JA; Jiménez-Jiménez FJ; Tejeda R; Ledesma MC; Ortí-Pareja M; Gasalla T; Molina JA; Ruiz J; Coria F; Duarte J; Vázquez A; Ladero JM; Benítez J
    Eur Neurol; 1997; 38(2):99-104. PubMed ID: 9286632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis.
    Dahl ML; Johansson I; Bertilsson L; Ingelman-Sundberg M; Sjöqvist F
    J Pharmacol Exp Ther; 1995 Jul; 274(1):516-20. PubMed ID: 7616439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution.
    Marez D; Legrand M; Sabbagh N; Lo Guidice JM; Spire C; Lafitte JJ; Meyer UA; Broly F
    Pharmacogenetics; 1997 Jun; 7(3):193-202. PubMed ID: 9241659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype and genotype analysis of debrisoquine hydroxylase (CYP2D6) in a black Zimbabwean population. Reduced enzyme activity and evaluation of metabolic correlation of CYP2D6 probe drugs.
    Masimirembwa C; Hasler J; Bertilssons L; Johansson I; Ekberg O; Ingelman-Sundberg M
    Eur J Clin Pharmacol; 1996; 51(2):117-22. PubMed ID: 8911874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the oxidative polymorphism and early onset of Parkinson's disease.
    Agúndez JA; Jiménez-Jiménez FJ; Luengo A; Bernal ML; Molina JA; Ayuso L; Vázquez A; Parra J; Duarte J; Coria F
    Clin Pharmacol Ther; 1995 Mar; 57(3):291-8. PubMed ID: 7697946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP2D6 polymorphism in systemic lupus erythematosus patients.
    Kortunay S; Bozkurt A; Bathum L; Basci NE; Calgüneri M; Brøsen K; Kayaalp SO
    Eur J Clin Pharmacol; 1999 Mar; 55(1):21-5. PubMed ID: 10206080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of -330 interleukin-2 gene polymorphism and HLA-DR15 allele in Iranian patients with multiple sclerosis.
    Sayad A
    Int J Immunogenet; 2014 Aug; 41(4):330-4. PubMed ID: 24919928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Debrisoquine hydroxylase gene polymorphism frequencies in patients with amyotrophic lateral sclerosis.
    Siddons MA; Pickering-Brown SM; Mann DM; Owen F; Cooper PN
    Neurosci Lett; 1996 Apr; 208(1):65-8. PubMed ID: 8731176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis of the CYP2D6 gene in patients with Parkinson's disease.
    Tsuneoka Y; Matsuo Y; Ichikawa Y; Watanabe Y
    Metabolism; 1998 Jan; 47(1):94-6. PubMed ID: 9440484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age- and gender-specific effects on VDR gene polymorphisms and risk of the development of multiple sclerosis in Tunisians: a preliminary study.
    Ben-Selma W; Ben-Fredj N; Chebel S; Frih-Ayed M; Aouni M; Boukadida J
    Int J Immunogenet; 2015 Jun; 42(3):174-81. PubMed ID: 25892553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the CYP2D6 gene in relation to debrisoquin and desipramine hydroxylation in a Swedish population.
    Dahl ML; Johansson I; Palmertz MP; Ingelman-Sundberg M; Sjöqvist F
    Clin Pharmacol Ther; 1992 Jan; 51(1):12-7. PubMed ID: 1346258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No association between CYP2D6 polymorphism and Alzheimer's disease in an Italian population.
    Scordo MG; Dahl ML; Spina E; Cordici F; Arena MG
    Pharmacol Res; 2006 Feb; 53(2):162-5. PubMed ID: 16337409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
    Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A
    J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous genotyping of CYP2D6*3, *4, *5 and *6 polymorphisms in a Spanish population through multiplex long polymerase chain reaction and minisequencing multiplex single base extension analysis.
    Crescenti A; Mas S; Gassó P; Baiget M; Bernardo M; Lafuente A
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):992-7. PubMed ID: 17714084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of the CYP2D6*10 (C100T), *4 (G1846A), and *14 (G1758A) alleles among Iranians of different ethnicities.
    Bagheri A; Kamalidehghan B; Haghshenas M; Azadfar P; Akbari L; Sangtarash MH; Vejdandoust F; Ahmadipour F; Meng GY; Houshmand M
    Drug Des Devel Ther; 2015; 9():2627-34. PubMed ID: 25999696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.
    Scordo MG; Caputi AP; D'Arrigo C; Fava G; Spina E
    Pharmacol Res; 2004 Aug; 50(2):195-200. PubMed ID: 15177309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 CYP2D6.
    Wolf CR; Smith G
    IARC Sci Publ; 1999; (148):209-29. PubMed ID: 10493260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor gene polymorphism in Japanese patients with multiple sclerosis.
    Niino M; Kikuchi S; Fukazawa T; Yabe I; Tashiro K
    J Neurol Sci; 2000 Oct; 179(S 1-2):70-5. PubMed ID: 11054488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme gene polymorphism in patients with multiple sclerosis from Bosnia and Herzegovina.
    Klupka-Sarić I; Peterlin B; Lovrečić L; Sinanović O; Vidović M; Sehanović A; Cizmarević NS; Sepčić J; Kapović M; Ristić S
    Genet Test Mol Biomarkers; 2011 Nov; 15(11):835-8. PubMed ID: 21699406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.